Preference of Tegaserod vs. PEG 3350 in Patients With Constipation

Status:	Completed
Conditions:	Constipation
Therapuetic Areas:	Gastroenterology
Healthy:	No
Age Range:	18 - 64
Updated:	4/21/2016
Start Date:	May 2005
End Date:	September 2005

A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation

To determine whether female patients have a preference for tegaserod of PEG 3350 relative to
dosage form, convenience, ease of administration and taste

Inclusion Criteria:

- Females aged 18 to 64 years of age

- Patients with constipation as defined by the Rome II criteria

Exclusion Criteria:

- Patients who have been previously been treated with tegaserod and/or PEG 3350

- Evidence of cathartic colon or a history of laxative abuse or laxative dependence

- History of fecal impaction which necessitated surgical intervention

- Patients with clinically significant abnormal TSH levels at screening

- Women who are pregnant or breast feeding

Other protocol-defined inclusion/exclusion criteria may apply

We found this trial at

sites

Adobe Gastroenterology, PC

Tucson, Arizona 85712

from

Tucson, AZ